LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix International N.V., (NASDAQ:OFIX) (the "Company"), a
diversified, global medical device company, announced today that it
plans to release fourth quarter 2014 financial results after market
close on Wednesday, April 29, 2015. Brad Mason, Chief Executive Officer
and Doug Rice, Interim Chief Financial Officer will host a conference
call and webcast to review the Company's results at 4:30 p.m. EDT the
same day.
Interested parties may access the conference call by dialing (888)
267-2845 in the U.S. and (973) 413-6102 outside the U.S., and entering
the conference ID 38220. A replay of the call will be available for two
weeks by dialing (800) 332-6854 in the U.S. and (973) 528-0005 outside
the U.S., and entering the conference ID 38220. A webcast of the
conference call may be accessed by going to the Company's website at www.orthofix.com,
by clicking on the Investors link and then the Events and Presentations
page.
About Orthofix:
Orthofix International N.V. is a diversified, global medical device
company focused on improving patients' lives by providing superior
reconstructive and regenerative orthopedic and spine solutions to
physicians worldwide. Headquartered in Lewisville, Texas, the Company
has four strategic business units that include BioStim, Biologics,
Extremity Fixation and Spine Fixation. Orthofix products are widely
distributed via the Company's sales representatives, distributors and
its subsidiaries. In addition, Orthofix is collaborating on research and
development activities with leading clinical organizations such as the
Musculoskeletal Transplant Foundation and the Texas Scottish Rite
Hospital for Children. For more information, please visit www.orthofix.com.
Orthofix International N.V.
Investor
Contact:
Mark Quick, 214-937-2924
markquick@orthofix.com
or
Media
Contact:
Denise Landry, 214-937-2529
deniselandry@orthofix.com
Source: Orthofix International N.V.
News Provided by Acquire Media